Skip to content

Etiology and Early Diagnosis of Neurodevelopmental Disorders

Etiology and Early Diagnosis of Neurodevelopmental Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02003170
Enrollment
576
Registered
2013-12-06
Start date
2012-05-31
Completion date
2024-06-06
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Disorders

Keywords

Autism, Autism Spectrum Disorder (ASD), Pervasive Developmental Disorder (PDD), Developmental delays, Genetic disorder, Mitochondrial disorder

Brief summary

The purpose of this study is to systematically evaluate the results of medical investigations to identify symptom and biological patterns and common etiologies of neurodevelopmental disorders.

Detailed description

Although neurodevelopmental disorders are very prevalent (for example Autism affects 1 out of every 88 children and dyslexia affects up to 15% of the population), the etiology of such disorders is not known. The purpose of this investigation is to identify common etiologies of neurodevelopmental disorders (i.e., speech delay, global developmental delay, autism) and determine if it is possible to find early indicators of the diagnosis and foster the potential for a better prognosis of these disorders. At this time the investigators examine patients with neurodevelopment disorders with various medical investigations, but the results of these investigations are not systematically evaluated. One of the goals of this research is to systematically examine this information in order to identify patterns of test abnormalities that have not been previously described. Another goal of this research is to identify the common etiologies typically identified by the medical evaluation, so we can further refine our approach. In addition, the investigators now have the ability to evaluate biological samples for biomarkers that have potential to be diagnostically useful.

Interventions

None listed

Sponsors

Arkansas Children's Hospital Research Institute
CollaboratorOTHER
University of Arkansas
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Months to 99 Years
Healthy volunteers
No

Inclusion criteria

* Neurodevelopmental delays * Clinical visit at an Arkansas Children's Hospital Outpatient clinic

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Medical abnormalities associated with specific neurodevelopmental disordersup to 7 yearsIt is unknown if a specific set of biological abnormalities contribute to the formation of many types of neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders

Secondary

MeasureTime frameDescription
Biomarkers associated with neurodevelopmental disordersup to 7 yearsIt is unknown if a specific biomarkers are associated with specific neurodevelopmental disorders. The study is intended to identify the relationship between biological abnormalities and neurodevelopmental disorders
Treatments associated with neurodevelopmental disordersup to 7 yearsVarious behavioral and medical treatments are used for many types of neurodevelopmental disorders but the effectiveness for many of these treatments is not known. The study is intended to identify the relationship between biological abnormalities (and their treatments) and neurodevelopmental disorders

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026